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One of the deleterious effects of acute nerve agent exposure is the induction of status epilepticus (SE). If SE is
not controlled effectively, it causes extensive brain damage. Here, we review the neuropathology observed after
nerve agent–induced SE, as well as the ensuing pathophysiological, neurological, and behavioral alterations, with
an emphasis on their time course and longevity. Limbic structures are particularly vulnerable to damage by nerve
agent exposure. The basolateral amygdala (BLA), which appears to be a key site for seizure initiation upon exposure,
suffers severe neuronal loss; however, GABAergic BLA interneurons display a delayed death, perhaps providing a
window of opportunity for rescuing intervention. The end result is a long-term reduction of GABAergic activity in
the BLA, with a concomitant increase in spontaneous excitatory activity; such pathophysiological alterations are not
observed in the CA1 hippocampal area, despite the extensive neuronal loss. Hyperexcitability in the BLA may be at
least in part responsible for the development of recurrent seizures and increased anxiety, while hippocampal damage
may underlie the long-termmemory impairments. Effective control of SE after nerve agent exposure, such that brain
damage is also minimized, is paramount for preventing lasting neurological and behavioral deficits.
Keywords: nerve agents; status epilepticus; seizures; basolateral amygdala; hippocampus; anxiety
Introduction
Nerve agents are organophosphorus compounds
that inhibit acetylcholinesterase (AChE) via
phosphorylation of a serine hydroxyl group at
the esteratic site of the enzyme,1 resulting in
the accumulation of acetylcholine in cholinergic
synapses of the peripheral and central nervous
systems.2,3 One of the consequences of the excessive
rise of acetylcholine in the brain is the induction
of seizures, which rapidly progress to convulsive
status epilepticus (SE). Unfortunately, surviving the
exposure is unlikely to lead to recovery unless the
nerve agent–induced SE is adequately controlled.
This is because prolonged SE––of any etiology––
can cause profound brain damage.4 The severity
and brain localization of the neuropathological
damage will determine to a great extent the severity
and nature of the ensuing neurological and/or
behavioral abnormalities.
In this review, we examine (1) which brain struc-
tures have been found to suffer the most severe
neuropathology after nerve agent–induced SE, (2)
what is known about differences in the susceptibility
of principal neurons versus GABAergic interneu-
rons to damage induced by nerve agent exposure,
(3) pathophysiological alterations in affected brain
regions, and(4)neurological andbehavioral impair-
ments. The time course and duration of these post-
exposure abnormalities are emphasized, so that it
becomes clear whether they are transient or whether
they persist for a long time, which would make the
control of nerve agent–induced SE imperative not
doi: 10.1111/nyas.13028
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only in order to save the life of the individual but also
to prevent brain damage and its impact on quality
of life.
Brain structures injured by nerve
agent–induced SE
Assessment of brain damage by nerve agent–
induced SE is performed primarily in animal mod-
els of exposure, using rodents in the majority of
studies. The peripheral cholinergic crisis is typically
treated with a muscarinic receptor antagonist and
an oxime (which reactivates the inhibited AChE)
administered before or soon after exposure to a
nerve agent, and then the animal is allowed to expe-
rience SE for various durations, until SE is stopped
by injection of an anticonvulsant or stops sponta-
neously. Soman has been the most commonly used
nerve agent in these experiments, mainly because
it is assumed that if an anticonvulsant treatment
is effective against soman––an agent whose toxic
effects are difficult to counteract––it should also be
effective against other nerve agents. Although this
is probably a reasonable assumption, there are not
enough comparative data to confirm its validity. In
general, there are differences between nerve agents
in parameters such as LD50, dose of an anticonvul-
sant required to suppress seizures, or the degree to
which they inhibit AChE in different brain regions
and peripheral tissues,3 but there are no reports on
qualitative differences in their toxic effects. In the
studies reviewed below, when the findings are from
exposure to one specific nerve agent, the type of
agent is stated.
Brain pathology caused by nerve agent expo-
sure is most commonly assessed by determining
the extent of neurodegeneration in different brain
regions, using methods such as selective staining
of degenerating neurons with Fluoro-Jade dyes,5,6
and/or by quantifying neuronal loss in brain regions
of interest. The findings from these studies have sug-
gested that the main cause of neuronal damage is
the prolonged seizure activity, as degenerating neu-
rons are found only in rats that develop seizures
after exposure to soman,7–9 and neuropathology
is dramatically reduced when seizures are ade-
quately controlled,10–15 regardless of the type of
nerve agent used.10 The mechanisms by which pro-
longed unremitting seizures can kill neurons involve
excitotoxicity,16,17 oxidative stress,18,19 and inflam-
matory processes.20,21
The damage seen after nerve agent–induced SE
is widespread and includes neocortical areas, the
thalamus, and subcortical structures.7,22,23 Limbic
structures, and particularly the amygdala and the
hippocampus, but also the piriform and entorhi-
nal cortices, suffer extensive damage.10–13,15,23,24 We
have examined this in more detail in an attempt to
delineate whether there are certain regions of the
amygdala and the hippocampus that are more sus-
ceptible than others to nerve agent–induced seizure
damage and whether, overall, the amygdala and the
hippocampus are similarly susceptible. We found
that the ventral hippocampushad significantlymore
neurodegeneration than the dorsal hippocampus, 1
day after soman-induced SE in rats.25 By 7 days pos-
texposure, the ventral hippocampus still had more
degenerating neurons, but the difference from the
dorsal area was not statistically significant, proba-
bly due to the loss of many degenerating neurons
during the 7-day period. The damage was present
in the CA1, CA3, and hilar hippocampal subfields.
We also found more severe neurodegeneration in
the posteroventral regions of the lateral, basolat-
eral (BLA), and medial amygdala nuclei compared
to the anterodorsal regions of these nuclei. Over-
all, the extent of neurodegeneration in the whole
amygdala was greater when compared with the
whole hippocampus (both dorsal and ventral), but
did not significantly differ from that in the ventral
hippocampus.25
The BLA plays a central role in emotional behav-
ior and, therefore, in the behavioral deficits that
arise when this brain region is damaged. We have
studied the time course of neuropathological alter-
ations in the BLA after exposure of young-adult
rats to soman, and have found that the number of
degenerating neurons is the highest at 24 h postex-
posure and decreases over the course of 30 days.24
Neuronal loss, determined by performing unbiased,
design-based stereological counting ofNissl-stained
neurons, is also already significant at 24 h postex-
posure, and there is no recovery at 14 or 30 days
postexposure,24 suggesting that neuronal regenera-
tion that takes place in the amygdala after seizure-
induced injury26 cannot compensate for the lost
neurons, at least during this time period after the
exposure.
Neuropathology data also exist at time intervals
longer than 1 month after nerve agent intoxica-
tion. Ninety days after exposure of adult mice to
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soman, the number of neurons in the amygdala and
the hippocampus is still significantly lower com-
pared to controls.26 In postnatal day 21 rats that
are exposed to soman, there are no degenerating
neurons after soman exposure, yet both the amyg-
dala and the hippocampus are significantly smaller
compared to control animals at 30 and 90 days
after the exposure;27 thus, despite the resistance of
neurons in the developing brain to seizure-induced
degeneration and death,28 other abnormalities such
as seizure-induced metabolic changes29 may affect
dendritic arborizations and overall synaptic organi-
zation, producing amygdala and hippocampal atro-
phy in the long term. Neuropathology that includes
hippocampal atrophy has also been reported after
exposure of adult rats to soman or sarin, and it
is still present and progressively deteriorating at
90 days after exposure,22,23 while long-lasting atro-
phy of the whole brain has been found in guinea
pigs after soman exposure.30
Atrophy in a number of brain regions has also
been observed in victims of the terrorist attack in
the Tokyo subway in 1995, when the nerve agent
sarin was released. Five to six years after the attack,
victims presented with significant decrease in gray
matter volume in the right insular cortex, the right
temporal cortex, and the left hippocampus,31 as well
as reduced volume of the anterior cingulate cortex32
and the amygdala.33 Information is not provided
regarding the occurrence and duration of seizures in
these human studies, but it is stated that the subjects
“were treated in the emergency room for acute sarin
intoxication,” which probably implies presence of
seizures.
Susceptibility of principal neurons versus
GABAergic interneurons
As discussed above, many brain regions are injured
by nerve agent–induced SE, but the amygdala and
the hippocampus have been studied more exten-
sively because they are consistently found to suf-
fer severe damage; another reason is probably that
these two structures play central––and, for themost
part, well-delineated––roles in memory and affec-
tive functions, which allows for more direct cor-
relations of their pathology and pathophysiology
with the resulting behavioral deficits. Knowing the
extent of neuronal loss in these regions can help
explain pathophysiological alterations and behav-
ioral abnormalities; however, also knowing the rel-
ative loss of excitatory neurons versus inhibitory
interneurons can help explain alterations in the
basal activity level and excitability of these neu-
ronal networks, parameters that can profoundly
affect their function. It is important, therefore, to
review the existing information regarding the loss
of principal/glutamatergic neurons versus the loss of
GABAergic interneurons after nerve agent–induced
SE; the data available have been obtained in theBLA,
following exposure to soman.
Despite the extensive neuronal loss in the rat BLA
at 24 h after soman exposure,11,12,15,24 immunohis-
tochemistry for GAD-67 has revealed that the num-
ber of GABAergic interneurons is not reduced at
this time point.11,24 In contrast, 7 days later, there
is a 46% decrease in the interneuron population,
with the ratio of interneurons to the total number
of neurons being significantly lower compared to
control rats at 14 and 30 days after the exposure24
(Fig. 1A). Thus, there is loss of both principal cells
and interneurons in the BLA after nerve agent–
induced SE, but the interneurons follow a slow time
course of death. Eventually, the BLA remains dam-
agednot onlywith a reduced overall neuronal popu-
lation but alsowith a greater deficiency in inhibitory
interneurons. Therefore, the absence of interneuron
loss at 24 h after exposure cannot be interpreted
to imply that these cells are more resistant to SE
induced by nerve agents, only that their mecha-
nism of death is slower. Since a significant num-
ber of principal cells have already been lost at 24
h postexposure,11,12,15,24 interneurons lose some of
their inputs and targets, which may contribute to
their gradual death. However, regardless of the pos-
sible role that this may play in the delayed death
of GABAergic interneurons, it is well known that
the time course of neuronal death can vary widely.
The same neuronal population can undergo either
an immediate, necrotic death or a slow, apoptotic
death after excitotoxic damage; necrosis is associ-
atedwith immediate loss ofmitochondrial function,
while apoptosis ensues in neurons that recover their
mitochondrial function and energy levels, yet in
which the excitotoxic insult has activated an endoge-
nous cell death program.34 Principal BLA cells can
undergo immediate, necrotic death (cell loss by 24 h
after exposure) or slow, apoptotic-like death (since
neurodegeneration continues for days after the ini-
tial 24 h postexposure); regenerative processes may
be overlapping,26,35 as suggested by the observation
19Ann. N.Y. Acad. Sci. 1374 (2016) 17–28 C© 2016 New York Academy of Sciences.
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Figure 1. Status epilepticus (SE) induced by exposure to soman causes severe neuronal loss in the basolateral amygdala (BLA)
that leads to long-term increases in the excitability of the BLA network and increased anxiety-like behavior. (A) Fourteen days after
exposure of rats to soman (1.2× LD50), there is a significant reduction in the total number of neurons––as determined by unbiased
design-based stereological counting in Nissl-stained sections––and GABAergic interneurons in the BLA, with a decrease in the
ratio of GABAergic to the total number of neurons in comparison to control rats. Photomicrographs in the top show Nissl-stained
(left) and GAD-67 labeled (right) sections from the BLA of control rats and soman-exposed rats, 14 days after the exposure. Bar
graphs show the group data on neuronal loss (data are from Ref. 24). (B) The frequency and amplitude of spontaneous IPSCs are
significantly reduced 14 days after soman-induced SE; representative traces are shown on the left and group data on the right (from
Ref. 41). (C) Anxiety-like behavior is increased after soman exposure, an impairment that persists at 90 days postexposure. The
time spent in the center of the open field is shown on the left, and the amplitude of the startle responses to acoustic stimuli on the
right (from Refs. 14 and 24).
that the percentage of lost neurons does not change
significantly up to 30 days postexposure, despite the
ongoing degeneration.24 GABAergic BLA interneu-
rons, on the other hand, seem to be less susceptible
to necrosis and more susceptible to apoptosis, for
reasons that remain to be determined.
The delayed death of BLA interneurons raises the
question of whether the mechanisms by which they
die allow for interventions that will reverse the pro-
cess and lead to their recovery. These mechanisms
need to be delineated, and may include processes
already known to be associated with apoptosis, such
as (1) excitotoxicity via activation of extrasynaptic
NMDA receptors;36 (2) facilitation ofNMDA recep-
tor activity, in some neurons, by upregulation of
d-serine, a positive NMDA receptor modulator;37
20 Ann. N.Y. Acad. Sci. 1374 (2016) 17–28 C© 2016 New York Academy of Sciences.
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(3) prolonged elevations of intracellular calcium
due to calcium-induced calcium release from intra-
cellular stores;16 and (4) alterations in the expres-
sion and activity of cell-death regulatory proteins.38
It has been argued that direct actions of the nerve
agent, independent of seizures, may also contribute
to delayed neuronal death.39
Pathophysiological alterations in the
amygdala and hippocampus after nerve
agent–induced SE
The neuronal injury and loss that follow SE
induced by nerve agent exposure can be expected
to produce pathophysiological alterations in the
affected regions, which in turn will affect their
function. However, there is very little information
available on such alterations, and what is available
is limited to the amygdala and, to a lesser extent,
the hippocampus. We will review it here, as these
structures are central to both epileptogenesis and
anxiety-related disorders or cognitive deficits that
commonly develop after nerve agent exposure (see
the next section).
We have examined the impact of the neuronal
loss on the physiology of the BLA, in in vitro
brain slices containing the amygdala. The field
potentials elicited in the BLA by stimulation of
the external capsule had much smaller amplitudes
in the soman-exposed rats compared to control
rats, requiring high stimulus intensities to evoke
a response.24 This weakening of evoked, gluta-
matergic field currents (for the receptors mediat-
ing BLA field potentials see Ref. 40), which was
probably due to damage and loss of glutamater-
gic neurons, had recovered only partially at 30 days
postexposure.24 Despite the low amplitude of the
BLA field potentials after soman-induced SE, their
duration was prolonged,14,24 which, along with an
increased paired-pulse ratio,14,24 suggests reduced
evoked inhibition; the prolonged duration of the
field potentials and the increased paired-pulse ratio
were still present at 30 days postexposure.14,24
In addition to the evoked inhibition, spontaneous
inhibitory activity is also reduced after soman-
induced SE, as reflected in the decreased frequency
and amplitude of spontaneous inhibitory postsy-
naptic currents (IPSCs) recorded from BLA prin-
cipal neurons (Fig. 1B), along with decreased fre-
quency of miniature IPSCs.41 These changes in
spontaneous GABAergic synaptic transmission are
already present at 24 h postexposure,41 when the
numberofGABAergic interneuronshasnot yet been
significantly reduced,11,24 suggesting that dysfunc-
tion of interneurons has already commenced at this
time point. Fourteen days later, the spontaneous
release ofGABA is still significantly reduced,withno
alterations in the amplitude of miniature IPSCs,41
reflecting the loss of GABAergic interneurons
and suggesting possible dysfunction in presynaptic
GABA release, with no postsynaptic alterations in
GABAA receptor–mediated synaptic transmission.
Neurotransmitter systems modulating GABAergic
transmission in the BLA may also be altered. For
example, in control rats, activation of 7 nicotinic
receptors produces a transient but dramatic increase
in the frequency and amplitude of spontaneous
IPSCs recorded from principal BLA cells,42 but this
effect is significantly less pronounced at 24 h and
14 days after soman-induced SE;41 to what extent
this is due to the reduced number of GABAergic
interneurons, desensitization of 7 nicotinic recep-
tors after the prolonged inhibition of AChE follow-
ing exposure to soman,24 or downregulationof these
receptors remains to be clarified. The net result of
the disproportional loss of BLA interneurons over
the loss of principal neurons and the decrease in
spontaneous GABAergic activity is an increase of
spontaneous EPSCs in the BLA network.41 In this
pathophysiological environment, synaptic plasticity
in the BLA is also impaired, albeit transiently.14,24
In the hippocampus, decreased frequency
of spontaneous excitatory postsynaptic currents
(EPSCs) recorded fromCA1 pyramidal neurons has
been observed at 6–9 days after soman exposure,43
whichprobably implies reduction in the glutamater-
gic inputs to these neurons because of neuronal
degeneration and loss in the CA1 and CA3 hip-
pocampal subfields.11–13,15 During this time (6–
9 days after exposure), the frequency of spontaneous
IPSCs in CA1 pyramidal neurons has returned to
control levels, after a transient reduction observed
at 24 h after exposure, while their amplitude is larger
than that in control rats.44 Thus, while in the BLA,
hyperexcitability prevails, in the CA1 hippocampal
area, inhibitory activity may be increased. It should
be noted that, in contrast to the observations in
the BLA, in the CA1 hippocampal area there is no
significant loss of GABAergic interneurons at
7 days after soman-induced SE, despite the exten-
sive reduction in the total number of neurons,11 an
21Ann. N.Y. Acad. Sci. 1374 (2016) 17–28 C© 2016 New York Academy of Sciences.
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observation that seems consistent with the lack of
reduction in the frequency of spontaneous IPSCs
at this time point.44 In the next sections, we
will examine if such alterations in the excitabil-
ity of the BLA and CA1 circuitries are compati-
ble with the observed neurological and behavioral
derangements.
Long-term neurological effects of nerve
agent exposure
Neurological evaluations have been performed in
victims of the sarin attacks in Matsumoto in 1994
and Tokyo in 1995. Although, in these human stud-
ies, there is significant heterogeneity in the severity
of the intoxication the subjects experienced and in
their resilience to nerve agent toxicity (partly due
to varying ages, gender, and possibly other factors),
it is evident that abnormal electroencephalographic
results suggestive of epileptiform activity are com-
mon and persistent for years after the incidents.45,46
Animal studies have shown that the neuronal
damage produced by a prolonged SE––of any
etiology––is often followed by epileptogenesis, lead-
ing to the appearance of recurrent seizures.47,48
Epileptogenesis also takes place after SE induced
by nerve agents.22,49 A large percentage of rats
who experience SE after soman exposure develop
spontaneous recurrent seizures, which first appear
5–10 days after the exposure49 and are present
throughout a 3-month postexposure observation
period.22 More than one brain region and mech-
anism may be involved in the epileptogenesis that
follows nerve agent–induced SE, but the significant
loss of interneurons in the BLA and the resulting
hyperexcitability is likely to play an important role.
The BLAhas been known to be a highly seizurogenic
neuronal network, and also one fromwhich seizures
can readily propagate to other brain regions.50 Evi-
dence suggests that theBLAmay also be the site from
which seizures propagate and progress to general-
ized SE after nerve agent exposure; the most impor-
tant pieces of evidence supporting this notion are
that (1) microinjection of nerve agents into differ-
ent brain regions can elicit convulsions only when
the nerve agent is injected into the BLA,51 and (2)
generation of SE after soman exposure requires sig-
nificant inhibition of AChE activity specifically in
the BLA.8 With reduced background inhibition and
a net increase in spontaneous excitatory activity,41
the BLA could be responsible for or contribute to
triggering spontaneous seizures.
The hippocampus is also well known to be a
seizurogenic structure, and therefore it may play
an essential role in the development of recurrent
seizures after nerve agent–induced SE. The ven-
tral hippocampus may be more important in this
regard, because it suffers more extensive neuronal
degeneration than the dorsal part25 and may have
a higher propensity than the dorsal hippocampus
for generating epileptiform activity.52 However, as
mentioned in the previous section, there is no sig-
nificant loss of GABAergic interneurons in the CA1
hippocampal area at 7 days after soman-induced
SE, despite the extensive reduction in the total
number of neurons,11 and, at about the same time
point, GABAergic activity is not reduced.44 It is not
known if inhibitory neurons and/or their activity
are reduced in the CA1 area at later postexposure
time points, but mechanisms other than reduced
GABAergic activity, such as aberrant reorganiza-
tion of hippocampal neuronal circuitries53,54 could
contribute to spontaneous recurrent seizures arising
from the hippocampus.
Long-term cognitive deficits and
behavioral disorders after nerve
agent exposure
Cognitive deficits related to learning and memory
have been observed after exposure to nerve agents.
In rats, there is impaired learning ability in the
Morriswatermaze at 2months after soman-induced
seizures.55 Filliat et al. studiedmice for up to 90 days
after soman-induced SE and found that impaired
performance in the Morris water maze, which tests
long-term spatial memory, and the T-maze, which
tests short-term spatial memory, persisted at the
90-day postexposure time point.56 The severity of
the memory impairment correlated with the sever-
ity of neuropathology in the CA1 hippocampal area,
as well as with the severity of convulsive SE as
deduced by the extent of weight loss.56 Similarly,
Collombet et al. found impaired performance in the
Morris water maze and T-maze at 30 and 90 days
after soman-induced SE, in mice.26 In the study by
Filliat et al., some soman-exposed mice that had
little or no neurodegeneration in the CA1 area dis-
playedmemorydeficits, but only in theMorriswater
maze test (not in the T-maze) and only at the 90-day
time point (not at 30 days postexposure), suggesting
22 Ann. N.Y. Acad. Sci. 1374 (2016) 17–28 C© 2016 New York Academy of Sciences.
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that even mild toxicity can produce delayed cogni-
tive deficits. Delayed impairment (3 months after
soman exposure) in the Morris water maze after
relatively mild intoxication has also been reported
in guinea pigs.57 There are also human data indi-
cating disturbances in memory functions and other
cognitive deficits long after acute organophosphate
intoxication. These data derive from accidental or
occupational exposure or from studies on the vic-
tims of the sarin terrorist attacks in Japan, and
seem to suggest that not only severe but even mild
organophosphate intoxication, without convulsive
SE, can produce cognitive disturbances (reviewed
in Ref. 39).
Correlations of the impairments in spatial
learning and memory with pathophysiological
alterations in the hippocampus after nerve agent
poisoning have not been made. However, it is well
established that hippocampal memory formation
is associated with and requires synaptic plasticity
in the hippocampus. It remains to be determined
whether the impaired spatial memory after nerve
agent exposure is associated with reduced synaptic
plasticity in the hippocampus and if this correlates
with neuronal damage, abnormal reorganization of
hippocampal neuronal circuitries, and/or increased
GABAergic inhibition.
Another behavioral abnormality that is consis-
tently observed after nerve agent–induced SE is
increased anxiety-like behavior. Seven to 9 days after
soman-induced SE, rats display elevated acoustic
startle responses.58 Studies at longer time intervals
after soman-induced SE also indicate increased anx-
iety; thus, the amount of time the rats spend in
the center of the open field is significantly reduced,
while the amplitudes of the startle responses to
acoustic stimuli are significantly increased, at 14,24
30,14,15,24 and 90 days14 after the exposure
(Fig. 1C). Similarly, mice exhibit increased anxiety
in the light/dark box and the elevated plus maze at
30 and 90 days after soman-induced SE.59
The animal data are in accord with findings
from studies of the victims of the sarin terror-
ist attack in Japan, which have revealed that the
main behavioral deficit present at 6–8 months
after the attack,60 and still persisting 5–7 years
later,46,61,62 is increased anxiety, with symptoma-
tology consistent with posttraumatic stress disor-
der (PTSD). In addition, 5–6 years after the sarin
Tokyo attack, victims with a history of PTSD had
atrophied amygdala,33 a pathology that has been
associated with anxiety disorders.63–65 The core fea-
ture, however, of anxiety disorders, including PTSD
in humans66,67 and increased anxiety-like behav-
ior in animals,68–70 is increased excitability of the
amygdala, and theBLA inparticular.66–70 Therefore,
the GABAergic interneuronal loss,11,24 decreased
GABAergic activity,41 and increased spontaneous
excitatory activity in the BLA,41 as observed in
animal studies, may explain the development of
increased anxiety after nerve agent exposure (Fig.
1A–C). It should also be noted that the ventral hip-
pocampus, which suffers severe damage after nerve
agent–induced SE,25 plays an important role in reg-
ulating anxiety along with the BLA;71 therefore, the
neuropathology of the ventral hippocampus may
also play an important role in the anxiety-related
behavioral derangements that develop after nerve
agent exposure.
The ample evidence of the association between
hyperexcitability of the amygdala and increased anx-
iety implies causality.72 In the case of the sarin attack
victims who developed PTSD, no studies have been
done to determine if their amygdala displays exag-
gerated responses to fearful stimuli, as typically seen
in PTSD patients;66,67 however, there is evidence for
pathology of the amygdala and other brain regions
that are involved in the expression of anxiety.33 The
prevailing assumption appears to be that PTSD in
these sarin attack victims developed due to stress
experienced during the terrorist attack and the con-
solidation of lasting fear memories. It is important,
however, to ask whether the emotional stress expe-
rienced during the attack produced the pathological
alterations that manifested behaviorally into PTSD,
or if sarin itself and/or the seizures induced by
exposure to sarin affected certain brain regions—
most importantly the amygdala––producing (or
contributing to) pathological and pathophysiolog-
ical alterations that resulted in the development
of PTSD. The animal data would suggest the lat-
ter. All rats that are exposed to a nerve agent and
undergo cholinergic crisis will experience stress, but
if neuropathology is minimized with administra-
tion of an anticonvulsant at 20 min14 or even 1 h15
after the exposure, the development of increased
anxiety-like behavior is prevented;14,15 these find-
ings suggest that it is the brain damage––induced
by seizures in this case––more than the stress that
produced increased anxiety. In support of this view,
23Ann. N.Y. Acad. Sci. 1374 (2016) 17–28 C© 2016 New York Academy of Sciences.
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Figure 2. Effective control of status epilepticus (SE) is necessary for the prevention of neuropathology and behavioral deficits.
The data presented here compare the efficacies of LY293558 (an AMPA/GluK1 receptor antagonist) and diazepam (DZP) against
soman. (A) Both LY293558 and DZP, administered 1 h after exposure of rats to soman (1.4 × LD50), terminated the initial SE,
but seizures returned in the DZP-treated rats; as a result, only LY293558 reduced the total duration of SE within 24 h after the
exposure. Electroencephalographic traces are shown on the left and group data on the right (from Refs. 11 and 15). (B) Neuronal
degeneration is prevented by LY293558, but not by DZP treatment. Data shown were obtained 7 days after the exposure. The
panoramic Nissl-stained sections (left) show the areas where neurodegeneration was evaluated, representative photomicrographs
of Fluoro-Jade C–stained sections from the amygdala (Amy) and the hippocampus are shown in the middle, and group data are
shown on the right (from Refs. 11 and 15). (C) Neuronal loss in the BLA and the CA1 hippocampal area is prevented by LY293558,
but not by DZP treatment. Data were obtained 7 days after the exposure. The panoramic Nissl-stained sections (left) show the
areas where neuronal loss was assessed. The Nissl-stained sections in the middle (total magnification 630×; scale bar, 50 m) are
representative photomicrographs from the four groups. The bar graph (right) shows group data (from Refs. 11 and 15). (D) Loss
of GABAergic interneurons in the BLA is prevented by LY293558, but not by DZP treatment. Data were obtained 7 days after the
exposure. The bar graph shows group data; representative photomicrographs from the corresponding groups are shown below the
graph (from Refs. 11 and 15).(E) Increased anxiety-like behavior, 30 days after soman exposure, was prevented by LY293558, but
not by DZP treatment. Left graph: time spent in the center of the open field. Right graph: amplitude of the startle responses to
120-dB acoustic stimulus (from Refs. 14 and 15).
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increased anxiety also develops after experimental
brain injury, which is inflicted while the animal is
anesthetized and probably does not experience any
severe stress;73 importantly, the injury induces loss
of GABAergic neurons and decreased spontaneous
GABAergic activity in theBLA.73 It is possible, there-
fore, that, in addition to the fear-eliciting memories
that contribute toPTSDsymptomatology, any insult
that will result in hyperexcitability of the amygdala
has the potential of producing or contributing to
the development of an anxiety disorder, including
PTSD.72
Controlling nerve agent–induced SE
prevents brain damage and the
long-term behavioral sequelae
Although mild nerve agent intoxication may pro-
duce long-term functional deficits39 via mecha-
nisms that are still unclear, there is a wealth of
evidence to suggest that the SE induced by the
exposure is the primary cause of the brain dam-
age and the long-term neurological and behavioral
sequelae.7–15 For this reason, the scientific commu-
nity has been actively seeking to discover new drugs
that will provide seizure control and neuroprotec-
tion in the event of an emergency involving the
release of nerve agents. It is not the purpose of this
review to describe these studies and compare the
efficacies of different drugs and drug combinations
that have been discovered. However, it is important
to point out that pharmacologically terminating the
initial SE will not necessarily prevent neuropathol-
ogy and its consequences; seizures and SE can return
and, therefore, they must be monitored for at least
24 h postexposure. We have observed the return of
seizures after stopping the initial soman-induced
SE by intramuscular injection of diazepam,15
which is the anticonvulsant currently approved by
the U.S. Food and Drug Administration for the
management of nerve agent–induced SE. Despite
the cessation of the initial SE by diazepam, the total
duration of SE within 24 h after exposure was not
lower in the diazepam-treated group compared to
the soman-exposed group that did not receive anti-
convulsant treatment (Fig. 2A); it is probably for
this reason that diazepam did not provide protec-
tion against neuronal degeneration (Fig. 2B), neu-
ronal loss (Fig. 2C and D), and behavioral deficits15
(Fig. 2E). Additional injections of diazepam as
seizures reappear may not only risk severe car-
diorespiratory suppression but may also have lit-
tle effectiveness in suppressing seizures, due to
downregulation and/or the many alterations that
occur in the synaptic and extrasynaptic GABAA
receptors in the acute phase, during and after
SE.74,75 Our studies have shown that anticonvul-
sant treatments are effective when they include
antagonism of the glutamatergic system;11–15 gluta-
mate receptors are not only not downregulated, but
their number increases during excessive excitatory
activity.75 The AMPA/GluK1 receptor antagonist
LY293558 has been exceptionally effective in sup-
pressing seizures11,13,14 (Fig. 2A), protecting against
neurodegeneration (Fig. 2B) and neuronal loss
(Fig. 2C and D), and preventing the development
of long-term increased anxiety (Fig. 2E). It must be
cautioned, however, that in these studies LY293558
has been compared with diazepam against only
one nerve agent (soman); it remains to be deter-
mined whether similar results would be obtained
with other nerve agents.
Conclusions
The studies reviewed above indicate that the neu-
ropathological, pathophysiological, neurological,
and behavioral alterations that are caused by acute
exposure to nerve agents are very long lasting. In
addition, the limited data available fromhumans are
consistent with the observations in animal models,
pointing to the validity of the use of these mod-
els; this is very important considering that it is
not ethical and feasible to use humans in studies
of nerve agent exposure. Effective control of SE is of
paramount importance, not only in order to prevent
death but also to prevent brain damage. Therefore,
new anticonvulsant treatments aiming at counter-
acting nerve agent–induced SEmust aim not only at
saving the lives of the exposed individuals but also at
providing sufficient neuroprotection to prevent the
development of long-term neurological and behav-
ioral impairments.
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